Entrepreneurs are ‘focussed’ on securing a COVID-19 vaccine

The ability “to make money and do good” is driving many entrepreneurs and venture capitalists to invest in projects designed to find a COVID-19 vaccine, according to OurCrowd CEO Jonathan Medved. There are almost 100 different projects worldwide aimed at finding a vaccine for the novel coronavirus, COVID-19. While some research groups have begun clinical trials, health experts warn a vaccine may not be developed for at least one year. OurCrowd has invested $12 million towards a newly formed medical firm, MigVax Corp, which Mr Medved believes has a “good shot” at finding a vaccine for the disease. He told Sky News "the race for the vaccine is the most important investment I have ever made.” “There is not going to be a single winner,” he said. “There are going to be many vaccines and many companies right now, there are almost 100 different projects worldwide and that’s a good thing." “It’s one of these situations that even if we don’t win, we win because as long as there is a vaccine brought to the world, we all win. This ability to present investors a double bottom line, the ability to both make money and do good is really important.” Via news.com.au — Australia’s #1 news site https://www.news.com.au